Hypoprothrombinaemia and bleeding associated with cephamandole.
D002435:Cefamandole / Q000009:adverse effects*; D002511:Cephalosporins / Q000009:adverse effects*; D006474:Hemorrhagic Disorders / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced* / Q000188:drug therapy; D011517:Prothrombin Time; D014812:Vitamin K / Q000627:therapeutic use
D002511:Cephalosporins; D014812:Vitamin K; D002435:Cefamandole